Ricovir 300mg Tablet

Ricovir 300mg tablet is an antiviral infection under the doctor prescription. The medication is used to treat hepatitis B virus (HBV) infection. Its active ingredient is Tenofovir Disoproxil Fumerate which belongs to the drug class of nucleotide reverse transcriptase inhibitors (NRTIs).. It works by inhibiting viral replication, lowering the amount of virus in the body and protecting the body.

It prevents the multiplication of virus within human cells. Doctor's prescription is required before using the medication to ensure safe and effective treatment option. It can be strictly followed as directed by the healthcare professional.

Treats hepatitis B viral (HBV) infection

Ricovir 300mg tablet can cause various side effects which are manageable with proper treatment option. Consult the healthcare professional if the symptoms persist:
• Tiredness
• Bloating, flatulence
• Low phosphate levels in the blood
• Diarrhea
• Dizziness
• Rash
• Weakness
• Pancreas problems
• Kidney damage
• Deep, rapid breathing
• Drowsiness
• Nausea, vomiting
• Infection
• Lactic acidosis
• Headache
• Stomach pain

Ricovir 300mg tablet should be taken with or without food in combination with other HIV medication. Taking this tablet at the same time everyday may help increase the treatment outcomes and maintain consistent drug levels in the body.

Do not overdose the medication at the missed one without doctor guidance. Do not continue this medication if any of the side effects persist, reach out to the doctor instantly.

Ricovir 300mg tablet is an antiviral medication. It works by inhibiting the reverse transcription enzyme which is essential for viral replication. By blocking this enzyme, it prevents the hepatitis B or HIV from multiplying thereby reducing the viral load in the body and helping to control the infection. This stops the virus from producing new viruses and clears up the infection.

• Gallant, J. E., & Deresinski, S. (2003). Tenofovir disoproxil fumarate. Clinical Infectious Diseases, 37(7), 944-950. https://pubmed.ncbi.nlm.nih.gov/13130407/
•  Wassner, C., Bradley, N., & Lee, Y. (2020). A review and clinical understanding of tenofovir: tenofovir disoproxil fumarate versus tenofovir alafenamide. Journal of the International Association of Providers of AIDS Care (JIAPAC), 19, 2325958220919231. https://pubmed.ncbi.nlm.nih.gov/32295453/
• Grim, S. A., & Romanelli, F. (2003). Tenofovir disoproxil fumarate. Annals of Pharmacotherapy, 37(6), 849-859. https://pubmed.ncbi.nlm.nih.gov/12773076/